Cutaneous synergistic analgesia of bupivacaine in combination with dopamine in rats

Jann Inn Tzeng, Jieh Neng Wang, Jhi Joung Wang, Yu Wen Chen, Ching Hsia Hung

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

The main goal of the study was to investigate the interaction between bupivacaine and dopamine on local analgesia. After the blockade of the cutaneous trunci muscle reflex (CTMR) responses, which occurred following the drugs were subcutaneously injected in rats, the cutaneous analgesic effect of dopamine in a dosage-dependent fashion was compared to that of bupivacaine. Drug-drug interactions were evaluated by isobolographic methods. We showed the dose-dependent effects of dopamine on infiltrative cutaneous analgesia. On the 50% effective dose (ED50) basis, the rank of drug potency was bupivacaine (1.99 [1.92-2.09] μmol/kg) greater than dopamine (190 [181-203] μmol/kg) (P < 0.01). At the equianalgesic doses (ED25, ED50, and ED75), dopamine elicited a similar duration of cutaneous analgesia compared with bupivacaine. The addition of dopamine to the bupivacaine solution exhibited a synergistic effect. Our pre-clinical data showed that dopamine produced a dose-dependent effect in producing cutaneous analgesia. When compared with bupivacaine, dopamine produced a lesser potency with a similar duration of cutaneous analgesia. Dopamine added to the bupivacaine preparation resulted in a synergistic analgesic effect.

Original languageEnglish
Pages (from-to)88-92
Number of pages5
JournalNeuroscience Letters
Volume620
DOIs
Publication statusPublished - 2016 May 4

Fingerprint

Bupivacaine
Analgesia
Dopamine
Skin
Analgesics
Pharmaceutical Preparations
Drug Interactions
Reflex
Muscles

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

@article{45ea3f6c8f5645288f325e5daff9b399,
title = "Cutaneous synergistic analgesia of bupivacaine in combination with dopamine in rats",
abstract = "The main goal of the study was to investigate the interaction between bupivacaine and dopamine on local analgesia. After the blockade of the cutaneous trunci muscle reflex (CTMR) responses, which occurred following the drugs were subcutaneously injected in rats, the cutaneous analgesic effect of dopamine in a dosage-dependent fashion was compared to that of bupivacaine. Drug-drug interactions were evaluated by isobolographic methods. We showed the dose-dependent effects of dopamine on infiltrative cutaneous analgesia. On the 50{\%} effective dose (ED50) basis, the rank of drug potency was bupivacaine (1.99 [1.92-2.09] μmol/kg) greater than dopamine (190 [181-203] μmol/kg) (P < 0.01). At the equianalgesic doses (ED25, ED50, and ED75), dopamine elicited a similar duration of cutaneous analgesia compared with bupivacaine. The addition of dopamine to the bupivacaine solution exhibited a synergistic effect. Our pre-clinical data showed that dopamine produced a dose-dependent effect in producing cutaneous analgesia. When compared with bupivacaine, dopamine produced a lesser potency with a similar duration of cutaneous analgesia. Dopamine added to the bupivacaine preparation resulted in a synergistic analgesic effect.",
author = "Tzeng, {Jann Inn} and Wang, {Jieh Neng} and Wang, {Jhi Joung} and Chen, {Yu Wen} and Hung, {Ching Hsia}",
year = "2016",
month = "5",
day = "4",
doi = "10.1016/j.neulet.2016.03.040",
language = "English",
volume = "620",
pages = "88--92",
journal = "Neuroscience Letters",
issn = "0304-3940",
publisher = "Elsevier Ireland Ltd",

}

Cutaneous synergistic analgesia of bupivacaine in combination with dopamine in rats. / Tzeng, Jann Inn; Wang, Jieh Neng; Wang, Jhi Joung; Chen, Yu Wen; Hung, Ching Hsia.

In: Neuroscience Letters, Vol. 620, 04.05.2016, p. 88-92.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Cutaneous synergistic analgesia of bupivacaine in combination with dopamine in rats

AU - Tzeng, Jann Inn

AU - Wang, Jieh Neng

AU - Wang, Jhi Joung

AU - Chen, Yu Wen

AU - Hung, Ching Hsia

PY - 2016/5/4

Y1 - 2016/5/4

N2 - The main goal of the study was to investigate the interaction between bupivacaine and dopamine on local analgesia. After the blockade of the cutaneous trunci muscle reflex (CTMR) responses, which occurred following the drugs were subcutaneously injected in rats, the cutaneous analgesic effect of dopamine in a dosage-dependent fashion was compared to that of bupivacaine. Drug-drug interactions were evaluated by isobolographic methods. We showed the dose-dependent effects of dopamine on infiltrative cutaneous analgesia. On the 50% effective dose (ED50) basis, the rank of drug potency was bupivacaine (1.99 [1.92-2.09] μmol/kg) greater than dopamine (190 [181-203] μmol/kg) (P < 0.01). At the equianalgesic doses (ED25, ED50, and ED75), dopamine elicited a similar duration of cutaneous analgesia compared with bupivacaine. The addition of dopamine to the bupivacaine solution exhibited a synergistic effect. Our pre-clinical data showed that dopamine produced a dose-dependent effect in producing cutaneous analgesia. When compared with bupivacaine, dopamine produced a lesser potency with a similar duration of cutaneous analgesia. Dopamine added to the bupivacaine preparation resulted in a synergistic analgesic effect.

AB - The main goal of the study was to investigate the interaction between bupivacaine and dopamine on local analgesia. After the blockade of the cutaneous trunci muscle reflex (CTMR) responses, which occurred following the drugs were subcutaneously injected in rats, the cutaneous analgesic effect of dopamine in a dosage-dependent fashion was compared to that of bupivacaine. Drug-drug interactions were evaluated by isobolographic methods. We showed the dose-dependent effects of dopamine on infiltrative cutaneous analgesia. On the 50% effective dose (ED50) basis, the rank of drug potency was bupivacaine (1.99 [1.92-2.09] μmol/kg) greater than dopamine (190 [181-203] μmol/kg) (P < 0.01). At the equianalgesic doses (ED25, ED50, and ED75), dopamine elicited a similar duration of cutaneous analgesia compared with bupivacaine. The addition of dopamine to the bupivacaine solution exhibited a synergistic effect. Our pre-clinical data showed that dopamine produced a dose-dependent effect in producing cutaneous analgesia. When compared with bupivacaine, dopamine produced a lesser potency with a similar duration of cutaneous analgesia. Dopamine added to the bupivacaine preparation resulted in a synergistic analgesic effect.

UR - http://www.scopus.com/inward/record.url?scp=84962276176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962276176&partnerID=8YFLogxK

U2 - 10.1016/j.neulet.2016.03.040

DO - 10.1016/j.neulet.2016.03.040

M3 - Article

C2 - 27019034

AN - SCOPUS:84962276176

VL - 620

SP - 88

EP - 92

JO - Neuroscience Letters

JF - Neuroscience Letters

SN - 0304-3940

ER -